logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Gilead Calistoga LLC


USPTO Granted Patents = 16



Forward Citations = 94

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Jerry B Evarts (12 out of 27 patents)

silverMedal Duong D Tran (7 out of 18 patents)

bronzeMedal Ernest A Carra (5 out of 20 patents)

4.  Fang Wang (5 out of 26 patents)

5.  Keiko Sujino (5 out of 16 patents)

6.  Roger G Ulrich (5 out of 12 patents)

7.  Neill A Giese (4 out of 11 patents)

8.  Brian Lannutti (3 out of 18 patents)

9.  Bing Shi (3 out of 40 patents)

10.  Stephane Perreault (3 out of 20 patents)

11.  Jennifer Anne Treiberg (3 out of 43 patents)

12.  Leena Patel (3 out of 23 patents)

13.  Michael J Gerber (3 out of 21 patents)

14.  W Michael Gallatin (3 out of 41 patents)

15.  Musong Kim (2 out of 25 patents)


16 patents:

1. 10730879 - Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one (2020-08-04),
2. 10442805 - Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one (2019-10-15),
3. 10154998 - Therapies for hematologic malignancies (2018-12-18),
4. 10059677 - Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof (2018-08-28),
5. 10047060 - Process methods for phosphatidylinositol 3-kinase inhibitors (2018-08-14),
6. 9708327 - Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one (2017-07-18),
7. 9492449 - Therapies for hematologic malignancies (2016-11-15),
8. 9469643 - Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one (2016-10-18),
9. 9266878 - Phosphatidylinositol 3-kinase inhibitors (2016-02-23),
10. 9238070 - Therapies for hematologic malignancies (2016-01-19),
11. 9029384 - Phosphatidylinositol 3-kinase inhibitors (2015-05-12),
12. 9018221 - Phosphatidylinositol 3-kinase inhibitors (2015-04-28),
13. 8865730 - [object Object] (2014-10-21),
14. 8691829 - Treatment of liver disorders with PI3K inhibitors (2014-04-08),
15. 8546409 - Methods of treatment for solid tumors (2013-10-01),
Gilead Calistoga LLC is a subsidiary of Gilead Sciences, Inc. It focuses on the discovery, development, and commercialization of innovative therapies for the treatment of life-threatening diseases. Gilead Calistoga LLC is dedicated to advancing science and improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

16 Patents

#31 in Foster City, CA

#4,639 in California

#19,327 in US

#36,703 in the World

...
Foster City, CA, United States of America

Gilead Calistoga LLC

Forward Citations = 94

27 inventors:

goldMedal Jerry B Evarts (12 out of 27 patents)

silverMedal Duong D Tran (7 out of 18 patents)

bronzeMedal Ernest A Carra (5 out of 20 patents)

4.  Fang Wang (5 out of 26 patents)

5.  Keiko Sujino (5 out of 16 patents)

Please report any incorrect information to support@idiyas.com
Loading…